T. Rowe Price Associates’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-24,747
| Closed | -$481K | – | 2617 |
|
|
2018
Q1 | $481K | Buy |
24,747
+143
| +0.6% | +$2.78K | ﹤0.01% | 2098 |
|
|
2017
Q4 | $410K | Hold |
24,604
| – | – | ﹤0.01% | 2151 |
|
|
2017
Q3 | $499K | Sell |
24,604
-8,300
| -25% | -$168K | ﹤0.01% | 2082 |
|
|
2017
Q2 | $530K | Sell |
32,904
-4,130
| -11% | -$66.5K | ﹤0.01% | 2043 |
|
|
2017
Q1 | $468K | Buy |
37,034
+12,764
| +53% | +$161K | ﹤0.01% | 2091 |
|
|
2016
Q4 | $322K | Buy |
24,270
+420
| +2% | +$5.57K | ﹤0.01% | 2228 |
|
|
2016
Q3 | $565K | Buy |
23,850
+3,810
| +19% | +$90.3K | ﹤0.01% | 1961 |
|
|
2016
Q2 | $578K | Hold |
20,040
| – | – | ﹤0.01% | 1905 |
|
|
2016
Q1 | $642K | Buy |
20,040
+460
| +2% | +$14.7K | ﹤0.01% | 1869 |
|
|
2015
Q4 | $837K | Buy |
19,580
+1,680
| +9% | +$71.8K | ﹤0.01% | 1750 |
|
|
2015
Q3 | $630K | Hold |
17,900
| – | – | ﹤0.01% | 1850 |
|
|
2015
Q2 | $822K | Buy |
17,900
+1,900
| +12% | +$87.3K | ﹤0.01% | 1810 |
|
|
2015
Q1 | $750K | Sell |
16,000
-2,300
| -13% | -$108K | ﹤0.01% | 1824 |
|
|
2014
Q4 | $580K | Hold |
18,300
| – | – | ﹤0.01% | 1904 |
|
|
2014
Q3 | $434K | Hold |
18,300
| – | – | ﹤0.01% | 1999 |
|
|
2014
Q2 | $549K | Hold |
18,300
| – | – | ﹤0.01% | 1908 |
|
|
2014
Q1 | $483K | Buy |
18,300
+3,800
| +26% | +$100K | ﹤0.01% | 1932 |
|
|
2013
Q4 | $365K | Sell |
14,500
-3,100
| -18% | -$78K | ﹤0.01% | 2049 |
|
|
2013
Q3 | $361K | Hold |
17,600
| – | – | ﹤0.01% | 2019 |
|
|
2013
Q2 | $351K | Buy |
+17,600
| New | +$351K | ﹤0.01% | 2005 |
|